Newlink Genetics Corp
- All
- News
-
NewLink Genetics Says Ebola Vaccine Trial Could Start in Weeks
NewLink Genetics Corp, which licensed an Ebola vaccine developed by Canadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday.
-
NewLink Says Ebola Vaccine Trial Could Start in Weeks
NewLink Genetics Corp, which licensed an Ebola vaccine developed by Canadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday.
-
NewLink Genetics Says Ebola Vaccine Trial Could Start in Weeks
NewLink Genetics Corp, which licensed an Ebola vaccine developed by Canadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday.
-
NewLink Says Ebola Vaccine Trial Could Start in Weeks
NewLink Genetics Corp, which licensed an Ebola vaccine developed by Canadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday.
